Expanded indication criteria of living donor liver transplantation for hepatocellular carcinoma at one large-volume center. - Wikidata - awgldk - TriplyDB

Expanded indication criteria of living donor liver transplantation for hepatocellular carcinoma at one large-volume center.

Expanded indication criteria of living donor liver transplantation for hepatocellular carcinoma at one large-volume center.

http://www.wikidata.org/entity/Q38500293

about

A review of current status of living donor liver transplantation Liver transplantation for hepatocellular carcinoma beyond the Milan criteria: A review Role of liver transplantation for hepatocellular carcinoma Liver transplantation for hepatocellular carcinoma Multidisciplinary perspective of hepatocellular carcinoma: A Pacific Northwest experience.Strategies to improve outcome of patients with hepatocellular carcinoma receiving a liver transplantation Selection of patients of hepatocellular carcinoma beyond the Milan criteria for liver transplantation Liver transplantation for advanced hepatocellular carcinoma Update in management of hepatocellular carcinoma in Eastern population 2014 KLCSG-NCC Korea Practice Guideline for the Management of Hepatocellular Carcinoma 2014 Korean Liver Cancer Study Group-National Cancer Center Korea practice guideline for the management of hepatocellular carcinoma Outcomes of living and deceased donor liver transplant recipients with hepatocellular carcinoma: results of the A2ALL cohort.Identifying candidates with favorable prognosis following liver transplantation for hepatocellular carcinoma: Data mining analysis.Value of radiofrequency ablation in the treatment of hepatocellular carcinoma Current status of the organ replacement approach for malignancies and an overture for organ bioengineering and regenerative medicine.Hepatocellular carcinoma: review of current treatment with a focus on targeted molecular therapies.Optimal tailored screening protocol after living donor liver transplantation for hepatocellular carcinoma From minimal to maximal surgery in the treatment of hepatocarcinoma: A review Patient and tumour biology predict survival beyond the Milan criteria in liver transplantation for hepatocellular carcinoma.The stratifying value of Hangzhou criteria in liver transplantation for hepatocellular carcinoma.NCCN clinical practice guidelines in oncology: hepatobiliary cancers Alpha-fetoprotein and novel tumor biomarkers as predictors of hepatocellular carcinoma recurrence after surgery: a brilliant star raises again.Can living donor liver transplantation offer similar outcomes to deceased donor liver transplantation using expanded selection criteria for hepatocellular carcinoma?Hepatocellular carcinoma: natural history, current management, and emerging tools.Living Donor Liver Transplantation Outcomes for Hepatocellular Carcinoma Beyond Milan or UCSF Criteria.Deceased-donor split-liver transplantation in adult recipients: is the learning curve over?Liver Transplantation for Hepatocellular Carcinoma beyond Milan Criteria: Multidisciplinary Approach to Improve Outcome.Liver transplantation for hepatocellular carcinoma in Ireland: Pre-operative alpha-fetoprotein predicts tumour recurrence in a 14-year single-centre national experience.Evaluation of eligibility criteria in living donor liver transplantation for hepatocellular carcinoma by α-SMA-positive cancer-associated fibroblasts.Indications for living donor liver transplantation in patients with hepatocellular carcinoma.Preoperative prognostic values of α-fetoprotein (AFP) and protein induced by vitamin K absence or antagonist-II (PIVKA-II) in patients with hepatocellular carcinoma for living donor liver transplantation.Liver transplantation for hepatocellular carcinoma: Korean experience.Liver transplantation for hepatocellular carcinoma: the Hong Kong experience.Liver transplantation for hepatocellular carcinoma: current topics in France.Liver Transplantation: East versus West.Prognosis of Hepatocellular Carcinoma after Liver Transplantation: Comparative Analysis with Partial Hepatectomy.Liver transplantation for HCC: its role: Eastern and Western perspectives.Living-donor liver transplantation in adults.Current controversies surrounding liver transplantation for hepatocellular carcinoma.Does living donation have advantages over deceased donation in liver transplantation?

P2860

Q26749857-53AC0EBE-2ED6-4F46-AA72-F4BD06ABF5CD Q26750463-C32B5CB8-85A7-4814-88F1-3A6DAD01D53D Q26822581-BB5E06F9-CB14-426E-8336-3ACC034B9CEA Q26997618-2A2F0337-15C6-464F-B73D-5FD3622CFA3B Q26998606-C668BA62-5D55-4B93-A36C-AAF3DE711E22 Q27005375-2AF61E96-5F38-4F3A-859E-337C6A9C5D95 Q27014758-5040D20B-C1FF-4956-9A67-6C102CF6C103 Q28074653-A0E25440-0CFD-47AF-A26B-291F067F26C8 Q28080480-6019CBF1-7D38-4083-8B36-A6C75963F7E6 Q28392783-872CAFB7-BD50-4867-AF54-0ED22926378C Q28394414-2BA7B06F-029D-41CC-937D-6C8B834B5CD8 Q30416480-FC42DA44-0329-4100-9C85-AC465DF82469 Q30962577-21A1C0F7-678A-4E67-910D-589A65F8E4AC Q33661046-1F1B6C83-06E2-457E-9EE8-B5A9A98711A4 Q34135201-07EBC642-B195-4E5D-A6FB-04EE19F84CBD Q34409128-29E5B977-0B5E-4318-957C-29EAED793D8E Q34429511-7D39C958-2A4B-4CDB-8772-DE2D9AE3574C Q34966860-62E92AE2-409B-4703-B606-FC1FC8FFDB1C Q34986197-8A9E7334-F301-4015-AE7D-BB5DB2CF3820 Q35133600-87DE9CBC-C3AE-4AD5-8AC8-1626B4EF0C5F Q35703937-A0580551-46F0-4261-A9F3-BF1A52B48A05 Q36082480-48078224-56A6-41A7-8604-6AF675EF694C Q36111140-2CE7A1C0-CF93-4FEF-9D43-B04F60CC0F96 Q36171275-F066BCE4-CFEA-419C-846B-3B809FAAB17C Q36643551-00F22C98-F539-49C5-86D3-8E1B30044C74 Q36926615-B16417E2-34F9-4D08-9046-7296D5CC2B2A Q36962089-ADCB8FC4-EABD-4A1F-9498-969D96EDEF1A Q37035208-4171336E-8D4A-44ED-A3AE-52FF701BC4EA Q37260604-7061B4A2-D975-4360-B337-7047B985CC29 Q37360166-ED2CB614-E624-4D32-9472-B9194047EEEB Q37568646-C70FCF51-4E7C-4BBF-8566-9862D5054535 Q37591234-1B3ABCFE-87BF-4EDF-B03B-AA9A67814882 Q37598591-FCDF5544-BB96-49AD-A071-B1FDB1CD9AD3 Q37598642-3FFA079A-48F7-400C-8E91-24CB1555D7E6 Q37613378-1A77FEE4-CCF5-45DB-B66F-69010D2BE908 Q37615300-D93A3856-7895-4B4E-8F5D-02539ABA5412 Q37626584-54BD3454-7482-4100-9275-69212F8CD1F0 Q37690026-5E7D8B23-F403-4323-83C9-3EFC2960D385 Q37769279-2BCFBF6D-83A9-4EF5-AB58-D7F869E75E6D Q37794228-146D4D77-B2B1-4C90-A3B6-3754D48DF5FE

P2860

Expanded indication criteria of living donor liver transplantation for hepatocellular carcinoma at one large-volume center.

http://www.wikidata.org/entity/Q38500293

description

2008 nî lūn-bûn

@nan

2008年の論文

@ja

2008年論文

@yue

2008年論文

@zh-hant

2008年論文

@zh-hk

2008年論文

@zh-mo

2008年論文

@zh-tw

2008年论文

@wuu

2008年论文

@zh

2008年论文

@zh-cn

name

Expanded indication criteria o ...... ma at one large-volume center.

@en

type

label

Expanded indication criteria o ...... ma at one large-volume center.

@en

prefLabel

Expanded indication criteria o ...... ma at one large-volume center.

@en

P1433

Q38500293-FF81C730-4D6E-4220-AE5D-0A317391B00B

P1476

Q38500293-02BD3C96-7CE5-4466-8612-131668206B1B

P2093

Q38500293-074C0332-0B56-4AAB-8936-FA188487EDA9

Q38500293-19B789CF-1589-42A8-A52F-D696FECC56D0

Q38500293-39807DE6-0AED-49BA-BF37-AF03BFD9E079

Q38500293-6E0B1739-31DD-4687-B8A2-5DD6E826EAB0

Q38500293-7F8CE77F-78B3-4C79-BB5A-B139DE8E8A4F

Q38500293-8AF66203-74FD-4A15-BF53-419597C05F39

Q38500293-99621C9E-09A7-454E-803E-53424AF8C2F1

Q38500293-B9CE3A18-DDE3-4A22-B3CA-58C181FA1CA7

Q38500293-C1EFAD1C-4A99-436A-8FBB-B845ACD70579

Q38500293-FBA112A8-FAF5-4E53-B643-34EFB6CE93DA

P304

Q38500293-8C807CF7-917F-4FB1-AFB4-C9E02BF9EE7B

P31

Q38500293-FDE6353E-958F-4361-BC1C-2A86DD0320B9

P356

Q38500293-B0CDE060-410A-473A-A862-D83DC28A0598

P433

Q38500293-3573509C-83CF-4121-82D6-D79DC3495EE4

P478

Q38500293-C4F6D342-4682-4DE2-A6D4-F309AC3A0BC1

P577

Q38500293-632A3494-1B3B-4355-840C-DC6D85348000

P5875

Q38500293-EDC70389-D4C1-42A1-B9D2-241838FAE4FF

P698

Q38500293-1AB8EE5C-C3E6-4C9D-92CB-95AF4AC6F094

P921

Q38500293-3D9CD9BB-E182-4802-9D67-A6AE6E09D1F8

P356

P1433

Liver Transplantation

P1476

Expanded indication criteria o ...... ma at one large-volume center.

@en

P2093

Chul-Soo Ahn

http://www.w3.org/2001/XMLSchema#string

Deok-Bog Moon

http://www.w3.org/2001/XMLSchema#string

Gi-Won Song

http://www.w3.org/2001/XMLSchema#string

Gi-Young Ko

http://www.w3.org/2001/XMLSchema#string

Ki-Hun Kim

http://www.w3.org/2001/XMLSchema#string

Kwang-Min Park

http://www.w3.org/2001/XMLSchema#string

Kyu-Bo Sung

http://www.w3.org/2001/XMLSchema#string

Shin Hwang

http://www.w3.org/2001/XMLSchema#string

Sung-Gyu Lee

http://www.w3.org/2001/XMLSchema#string

Tae-Yong Ha

http://www.w3.org/2001/XMLSchema#string

P304

935-945

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1002/LT.21445

http://www.w3.org/2001/XMLSchema#string

P433

7

http://www.w3.org/2001/XMLSchema#string

P478

14

http://www.w3.org/2001/XMLSchema#string

P577

2008-07-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

5273670

http://www.w3.org/2001/XMLSchema#string

P698

18581465

http://www.w3.org/2001/XMLSchema#string

P921

liver transplantation